Skip to content
lifestyle.d-h.st
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Medicenna Therapeutics Corp.
Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026
April 21, 2026
Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
April 14, 2026
Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim as Chief Medical Officer
April 9, 2026
←
Previous Page
1
2